🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators believe that the emerging epidemiological evidence connec...
Status
Completed
Location
Department of Dermatology and Allergy
Start Date
2019-08-22
Trial ID
NCT04114097
The objective of this phase 2 study is to evaluate the safety and efficacy ...
Status
Completed
Location
Multiple Locations
Start Date
2012-04-09
Trial ID
NCT01568489
Treatments Being Tested
The purpose of this trial is to test whether treatment with tralokinumab (a...
Status
Recruiting
Location
Leo Pharma Investigational site
Start Date
2024-06-10
Trial ID
NCT06311682
Treatments Being Tested
To study the etiology and the epigenetic pathways leading to and regulating...
Status
Withdrawn
Location
University of Minnesota
Start Date
2020-10-01
Trial ID
NCT04154033
Treatments Being Tested
Infants will be enrolled in this study if they have never been diagnosed wi...
Status
Completed
Location
Riley Hospital for Children
Start Date
2005-05
Trial ID
NCT00459576
Severe atopic dermatitis (AD) is a recurrent and debilitating disease often...
Status
Completed
Location
Multiple Locations
Start Date
2002-06
Trial ID
NCT02226068
Treatments Being Tested
Atopic dermatitis is a common problem faced by patients of all ages and bac...
Status
Completed
Location
Northwestern University Feinberg School of Medicine, Department of Dermatology
Start Date
2010-10
Trial ID
NCT01216059
Treatments Being Tested
The safety and efficacy of WAL 801 CL (epinastine hydrochloride) Dry Syrup ...
Status
Completed
Location
Multiple Locations
Start Date
2001-06
Trial ID
NCT02182570
Treatments Being Tested
The purpose of this study is to compare the efficacy and cost effectiveness...
Status
Completed
Location
Wake Forest Baptist Medical Center
Start Date
2009-09
Trial ID
NCT01093469
Treatments Being Tested
The study will assess the safety and efficacy of QGE031 in the treatment of...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-01-05
Trial ID
NCT01552629
Treatments Being Tested